EndoQuest Robotics

EndoQuest Robotics is a Houston, Texas medical device company — founded in 2017 and operating as ColubrisMX until its June 2022 rebrand — developing what it calls the world's first flexible endoluminal robotic surgical system. Its Endoluminal Surgical (ELS) System pairs an ergonomic physician console (high-definition monitor, hand controllers, foot pedals) with a mobile patient cart and positioning arm, driving two 6mm flexible robotic instruments and a 3.7mm high-definition robotic camera through the EndoDrive, with up to seven degrees of freedom and additional channels for insufflation, suction, irrigation and third-party accessories. The design targets scar-free minimally invasive procedures inside the gastrointestinal tract — including appendectomy and cholecystectomy — performed through natural orifices or a single transumbilical incision. The company was accepted into the FDA's Safer Technologies Program in December 2023, received an investigational device exemption in December 2024, and began first colorectal cases in its PARADIGM pivotal multicenter study in May 2025. The system is not FDA-cleared and is not for commercial sale. EndoQuest sells surgical robotics hardware, not software: it publishes no API, developer portal, SDK, or machine-readable contract of any kind, and its nine-page marketing site carries no developer surface.

EndoQuest Robotics is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Surgical Robotics, Robotics, and Endoluminal Surgery.

EndoQuest Robotics’ developer surface includes engineering blog and 12 more developer resources.

10.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyMedical DevicesSurgical RoboticsRoboticsEndoluminal SurgeryGastroenterologyMinimally Invasive SurgeryHealth CareMedical TechnologyDeep TechTexas

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 10.8/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.4 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/endoquest-robotics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Endoquest Robotics Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Operate 2

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 6

The organization behind the API

Other 2

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: endoquest-robotics
name: EndoQuest Robotics
description: 'EndoQuest Robotics is a Houston, Texas medical device company — founded in 2017 and operating as ColubrisMX
  until its June 2022 rebrand — developing what it calls the world''s first flexible endoluminal robotic surgical system.
  Its Endoluminal Surgical (ELS) System pairs an ergonomic physician console (high-definition monitor, hand controllers, foot
  pedals) with a mobile patient cart and positioning arm, driving two 6mm flexible robotic instruments and a 3.7mm high-definition
  robotic camera through the EndoDrive, with up to seven degrees of freedom and additional channels for insufflation, suction,
  irrigation and third-party accessories. The design targets scar-free minimally invasive procedures inside the gastrointestinal
  tract — including appendectomy and cholecystectomy — performed through natural orifices or a single transumbilical incision.
  The company was accepted into the FDA''s Safer Technologies Program in December 2023, received an investigational device
  exemption in December 2024, and began first colorectal cases in its PARADIGM pivotal multicenter study in May 2025. The
  system is not FDA-cleared and is not for commercial sale. EndoQuest sells surgical robotics hardware, not software: it publishes
  no API, developer portal, SDK, or machine-readable contract of any kind, and its nine-page marketing site carries no developer
  surface.'
image: https://endoquestrobotics.com/images/logo-header.svg
url: https://raw.githubusercontent.com/api-evangelist/endoquest-robotics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profile
x-tier-reason: no-api-surface
specificationVersion: '0.20'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Medical Devices
- Surgical Robotics
- Robotics
- Endoluminal Surgery
- Gastroenterology
- Minimally Invasive Surgery
- Health Care
- Medical Technology
- Deep Tech
- Texas
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://endoquestrobotics.com/
- type: Product
  url: https://endoquestrobotics.com/next-generation-robotic-surgery/
- type: Blog
  url: https://endoquestrobotics.com/latest-news/
- type: PressReleases
  url: https://endoquestrobotics.com/media/
- type: Careers
  url: https://endoquestrobotics.com/careers/
- type: Contact
  url: https://endoquestrobotics.com/contact/
- type: Patents
  url: https://endoquestrobotics.com/patent-notice/
- type: TermsOfService
  url: https://endoquestrobotics.com/terms-of-use/
- type: PrivacyPolicy
  url: https://endoquestrobotics.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/endoquest
- type: Twitter
  url: https://x.com/endoquestrobot
- type: Investors
  url: https://forgeglobal.com/endoquest-robotics_stock/
- type: DomainSecurity
  url: security/endoquest-robotics-domain-security.yml
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: EndoQuest Robotics manufactures a pre-commercial surgical robot — console, patient cart and 6mm flexible instruments
    — whose control software is embedded in the device and never exposed, and endoquestrobotics.com is a nine-page marketing
    site whose own sitemap.xml lists only home, contact, news, product, media, careers, patents, terms and privacy, with no
    /developers, no /api, no GitHub organization, and no api./docs./ developer. subdomain resolving in DNS.
  evidence:
  - url: https://endoquestrobotics.com/sitemap.xml
    status: 200
  - url: https://endoquestrobotics.com/developers
    status: 404
  - url: https://endoquestrobotics.com/openapi.json
    status: 404
  - url: https://endoquestrobotics.com/llms.txt
    status: 404
  - url: https://endoquestrobotics.com/.well-known/agent-card.json
    status: 404
  - url: https://endoquestrobotics.com/.well-known/agent.json
    status: 404
  - url: https://api.github.com/orgs/endoquestrobotics
    status: 404
  checked: '2026-08-12'